Details
Stereochemistry | RACEMIC |
Molecular Formula | C23H27FN4O3 |
Molecular Weight | 426.4839 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1=C(CCN2CCC(CC2)C3=NOC4=C3C=CC(F)=C4)C(=O)N5CCCC(O)C5=N1
InChI
InChIKey=PMXMIIMHBWHSKN-UHFFFAOYSA-N
InChI=1S/C23H27FN4O3/c1-14-17(23(30)28-9-2-3-19(29)22(28)25-14)8-12-27-10-6-15(7-11-27)21-18-5-4-16(24)13-20(18)31-26-21/h4-5,13,15,19,29H,2-3,6-12H2,1H3
Molecular Formula | C23H27FN4O3 |
Molecular Weight | 426.4839 |
Charge | 0 |
Count |
|
Stereochemistry | RACEMIC |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Optical Activity | ( + / - ) |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 16:17:28 UTC 2023
by
admin
on
Fri Dec 15 16:17:28 UTC 2023
|
Record UNII |
838F01T721
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Brand Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-ATC |
N05AX13
Created by
admin on Fri Dec 15 16:17:28 UTC 2023 , Edited by admin on Fri Dec 15 16:17:28 UTC 2023
|
||
|
WHO-VATC |
QN05AX13
Created by
admin on Fri Dec 15 16:17:28 UTC 2023 , Edited by admin on Fri Dec 15 16:17:28 UTC 2023
|
||
|
LIVERTOX |
NBK548506
Created by
admin on Fri Dec 15 16:17:28 UTC 2023 , Edited by admin on Fri Dec 15 16:17:28 UTC 2023
|
||
|
NDF-RT |
N0000175430
Created by
admin on Fri Dec 15 16:17:28 UTC 2023 , Edited by admin on Fri Dec 15 16:17:28 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
INVEGA (AUTHORIZED: PSYCHOTIC DISORDERS)
Created by
admin on Fri Dec 15 16:17:28 UTC 2023 , Edited by admin on Fri Dec 15 16:17:28 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
INVEGA (AUTHORIZED: SCHIZOPHRENIA)
Created by
admin on Fri Dec 15 16:17:28 UTC 2023 , Edited by admin on Fri Dec 15 16:17:28 UTC 2023
|
||
|
NCI_THESAURUS |
C66883
Created by
admin on Fri Dec 15 16:17:28 UTC 2023 , Edited by admin on Fri Dec 15 16:17:28 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
4137
Created by
admin on Fri Dec 15 16:17:28 UTC 2023 , Edited by admin on Fri Dec 15 16:17:28 UTC 2023
|
PRIMARY | |||
|
Paliperidone
Created by
admin on Fri Dec 15 16:17:28 UTC 2023 , Edited by admin on Fri Dec 15 16:17:28 UTC 2023
|
PRIMARY | |||
|
CHEMBL1621
Created by
admin on Fri Dec 15 16:17:28 UTC 2023 , Edited by admin on Fri Dec 15 16:17:28 UTC 2023
|
PRIMARY | |||
|
DTXSID7049059
Created by
admin on Fri Dec 15 16:17:28 UTC 2023 , Edited by admin on Fri Dec 15 16:17:28 UTC 2023
|
PRIMARY | |||
|
1491809
Created by
admin on Fri Dec 15 16:17:28 UTC 2023 , Edited by admin on Fri Dec 15 16:17:28 UTC 2023
|
PRIMARY | |||
|
PALIPERIDONE
Created by
admin on Fri Dec 15 16:17:28 UTC 2023 , Edited by admin on Fri Dec 15 16:17:28 UTC 2023
|
PRIMARY | |||
|
DB01267
Created by
admin on Fri Dec 15 16:17:28 UTC 2023 , Edited by admin on Fri Dec 15 16:17:28 UTC 2023
|
PRIMARY | |||
|
QQ-13
Created by
admin on Fri Dec 15 16:17:28 UTC 2023 , Edited by admin on Fri Dec 15 16:17:28 UTC 2023
|
PRIMARY | |||
|
7977
Created by
admin on Fri Dec 15 16:17:28 UTC 2023 , Edited by admin on Fri Dec 15 16:17:28 UTC 2023
|
PRIMARY | |||
|
838F01T721
Created by
admin on Fri Dec 15 16:17:28 UTC 2023 , Edited by admin on Fri Dec 15 16:17:28 UTC 2023
|
PRIMARY | |||
|
144598-75-4
Created by
admin on Fri Dec 15 16:17:28 UTC 2023 , Edited by admin on Fri Dec 15 16:17:28 UTC 2023
|
PRIMARY | |||
|
100000092109
Created by
admin on Fri Dec 15 16:17:28 UTC 2023 , Edited by admin on Fri Dec 15 16:17:28 UTC 2023
|
PRIMARY | |||
|
7258
Created by
admin on Fri Dec 15 16:17:28 UTC 2023 , Edited by admin on Fri Dec 15 16:17:28 UTC 2023
|
PRIMARY | |||
|
115237
Created by
admin on Fri Dec 15 16:17:28 UTC 2023 , Edited by admin on Fri Dec 15 16:17:28 UTC 2023
|
PRIMARY | |||
|
679314
Created by
admin on Fri Dec 15 16:17:28 UTC 2023 , Edited by admin on Fri Dec 15 16:17:28 UTC 2023
|
PRIMARY | RxNorm | ||
|
C66293
Created by
admin on Fri Dec 15 16:17:28 UTC 2023 , Edited by admin on Fri Dec 15 16:17:28 UTC 2023
|
PRIMARY | |||
|
838F01T721
Created by
admin on Fri Dec 15 16:17:28 UTC 2023 , Edited by admin on Fri Dec 15 16:17:28 UTC 2023
|
PRIMARY | |||
|
SUB23268
Created by
admin on Fri Dec 15 16:17:28 UTC 2023 , Edited by admin on Fri Dec 15 16:17:28 UTC 2023
|
PRIMARY | |||
|
m8357
Created by
admin on Fri Dec 15 16:17:28 UTC 2023 , Edited by admin on Fri Dec 15 16:17:28 UTC 2023
|
PRIMARY | Merck Index | ||
|
82978
Created by
admin on Fri Dec 15 16:17:28 UTC 2023 , Edited by admin on Fri Dec 15 16:17:28 UTC 2023
|
PRIMARY | |||
|
759623
Created by
admin on Fri Dec 15 16:17:28 UTC 2023 , Edited by admin on Fri Dec 15 16:17:28 UTC 2023
|
PRIMARY | |||
|
8148
Created by
admin on Fri Dec 15 16:17:28 UTC 2023 , Edited by admin on Fri Dec 15 16:17:28 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
OFF-TARGET->NON-INHIBITOR |
NON-INHIBITOR
Ki
|
||
|
METABOLIC ENZYME -> SUBSTRATE | |||
|
TARGET -> INHIBITOR |
INHIBITOR
Ki
|
||
|
TARGET -> INHIBITOR |
INHIBITOR
Ki
|
||
|
OFF TARGET->NON-INHIBITOR |
NON-INHIBITOR
Ki
|
||
|
TARGET -> INHIBITOR |
INHIBITOR
Ki
|
||
|
TARGET -> INHIBITOR |
INHIBITOR
Ki
|
||
|
EXCRETED UNCHANGED |
AMOUNT EXCRETED
URINE
|
||
|
TARGET -> INHIBITOR |
INHIBITOR
Ki
|
||
|
TARGET->WEAK INHIBITOR |
INHIBITOR
Ki
|
||
|
TARGET -> INHIBITOR |
INHIBITOR
Ki
|
||
|
TARGET -> INHIBITOR |
INHIBITOR
Ki
|
||
|
OFF TARGET->NON-INHIBITOR |
NON-INHIBITOR
Ki
|
||
|
TARGET -> INHIBITOR |
INHIBITOR
Ki
|
||
|
TARGET -> INHIBITOR |
INHIBITOR
Ki
|
||
|
TRANSPORTER -> SUBSTRATE |
TRANSPORTER
IC50
|
||
|
OFF TARGET->NON-INHIBITOR |
NON-INHIBITOR
Ki
|
||
|
BINDER->LIGAND |
|
||
|
TARGET -> INHIBITOR |
INHIBITOR
Ki
|
||
|
TARGET -> INHIBITOR |
INHIBITOR
Ki
|
||
|
TARGET -> INHIBITOR |
INHIBITOR
Ki
|
||
|
TARGET -> INHIBITOR |
INHIBITOR
Ki
|
||
|
OFF TARGET->NON-INHIBITOR |
NON-INHIBITOR
Ki
|
||
|
TARGET -> INHIBITOR |
INHIBITOR
Ki
|
||
|
TARGET -> INHIBITOR |
INHIBITOR
Ki
|
||
|
METABOLIC ENZYME -> SUBSTRATE | |||
|
TARGET -> INHIBITOR |
INHIBITOR
Ki
|
||
|
TARGET -> INHIBITOR |
INHIBITOR
Ki
|
||
|
TARGET -> INHIBITOR |
INHIBITOR
Ki
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE -> PARENT |
Trace in feces
URINE
|
||
|
METABOLITE -> PARENT |
FECAL
|
||
|
METABOLITE -> PARENT |
URINE
|
||
|
PARENT -> METABOLITE ACTIVE |
MAJOR
PLASMA
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
PARENT -> IMPURITY |
not more than the area of the principal peak in the chromatogram obtained with reference solution (b)
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
ORAL BIOAVAILABILITY | PHARMACOKINETIC |
|
|
|||
Biological Half-life | PHARMACOKINETIC |
|
|
|||
Volume of Distribution | PHARMACOKINETIC |
|
|
|||
Tmax | PHARMACOKINETIC |
|
|
|||